These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 39091353)

  • 21. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of Left Main Revascularization in Patients with Anemia: Gulf Left Main Registry.
    Daoulah A; Jameel Naser M; Hersi A; Yousif N; Alasmari A; Almahmeed W; AlZahrani HA; Aljohar A; Alshehri M; Alzahrani B; Basudan D; Alosaimi H; Abuelatta R; Al Garni T; Ghani MA; Amin H; Noor HA; Hashmani S; Al Nasser FOM; Kazim HM; Wael Refaat WR; Selim E; Jamjoom A; El-Sayed O; Hassan T; Dahdouh Z; Aithal J; Diab A; Ibrahim AM; Elganady A; Qutub MA; Alama MN; Abohasan A; Tawfik W; Balghith M; Abualnaja S; Fathey Hussien A; Abdulhabeeb IAM; Ahmad O; Ramadan M; Alqahtani AH; Al Samadi F; Qenawi W; Shawky A; Ghonim AA; Arafat AA; Elmahrouk A; Elmahrouk Y; Hiremath N; Shawky AM; Asrar FM; Farghali T; Altnji I; Aljohani K; Alotaiby M; Alqahtani AM; Lotfi A
    Cardiology; 2023; 148(3):173-186. PubMed ID: 36966525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of extended dual antiplatelet therapy on long-term prognosis in patients with acute coronary syndrome complicated with anemia: A sub-analysis of the real-world OPT-CAD study.
    Zhao Y; Li J; Ma S; Jiang Z; Li Z; Wang X; Han Y; Li Y
    Catheter Cardiovasc Interv; 2021 Aug; 98(2):E235-E242. PubMed ID: 33817946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and Clinical Correlates of Extended Mechanical Support in Patients Undergoing High-Risk Percutaneous Coronary Intervention in Current Clinical Practice: Insights from the cVAD Registry.
    Davila CD; Sharma S; Krishnamoorthy P; Rengifo-Moreno P; Palacios IF; O'Neill W; Kapur NK; Witzke CF
    Cardiovasc Revasc Med; 2020 Mar; 21(3):342-347. PubMed ID: 31227392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of left-ventricular end-diastolic pressure as a predictor of periprocedural hemodynamic deterioration in patients undergoing Impella supported high-risk percutaneous coronary interventions.
    Al-Rashid F; Mahabadi AA; Johannsen L; Soldat J; Dykun I; Jánosi RA; Totzeck M; Rassaf T
    Int J Cardiol Heart Vasc; 2020 Feb; 26():100445. PubMed ID: 31799370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implications of bleeding on subsequent cardiovascular events in patients with atrial fibrillation after acute coronary syndrome or PCI.
    Mo R; Wang HY; Yang YM; Zhang H; Suo N; Wang JY
    Thromb Res; 2023 Sep; 229():243-251. PubMed ID: 37591154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombocytopenia in patients with atrial fibrillation on oral anticoagulation undergoing percutaneous coronary intervention.
    Kiviniemi T; Karjalainen P; Rubboli A; Schlitt A; Tuomainen P; Niemelä M; Laine M; Biancari F; Lip GY; Airaksinen KE
    Am J Cardiol; 2013 Aug; 112(4):493-8. PubMed ID: 23672991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of anemia on percutaneous coronary intervention in Chinese patients: A large single center data.
    Jiang L; Gao Z; Song Y; Xu J; Tang X; Wang H; Liu R; Jiang P; Xu B; Yuan J
    J Interv Cardiol; 2018 Dec; 31(6):826-833. PubMed ID: 30467893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrovascular events after a primary percutaneous coronary intervention strategy for acute ST-segment-elevation myocardial infarction: analysis from the HORIZONS-AMI Trial.
    Nikolsky E; Mehran R; Dangas GD; Xu K; Parvataneni R; Witzenbichler B; Guagliumi G; Kornowski R; Généreux P; Brener SJ; Stone GW
    Circ Cardiovasc Interv; 2015 Apr; 8(4):. PubMed ID: 25858976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of sex, body mass index and chronic kidney disease on outcomes following percutaneous coronary intervention.
    Bimal T; Bhuiyan MR; Fishbein J; Ukrani J; Gandotra P; Selim S; Ong L; Gruberg L
    Cardiovasc Revasc Med; 2024 Feb; 59():37-45. PubMed ID: 37604707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impella Versus Non-Impella for Nonemergent High-Risk Percutaneous Coronary Intervention.
    Reddy P; Merdler I; Zhang C; Cellamare M; Ben-Dor I; Bernardo NL; Hashim HD; Satler LF; Rogers T; Waksman R
    Am J Cardiol; 2024 Aug; 225():4-9. PubMed ID: 38871158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential Event Rates and Independent Predictors of Long-Term Major Cardiovascular Events and Death in 5795 Patients With Unprotected Left Main Coronary Artery Disease Treated With Stents, Bypass Surgery, or Medication: Insights From a Large International Multicenter Registry.
    Kang SH; Ahn JM; Lee CH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    Circ Cardiovasc Interv; 2017 Jul; 10(7):. PubMed ID: 28701487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Impact of short-time anticoagulant therapy after selective percutaneous intervention on prognosis of patients with coronary artery disease].
    Song Y; Tang XF; Xu JJ; Wang HH; Liu R; Jiang P; Jiang L; Gao LJ; Zhang Y; Song L; Xu LJ; Zhao XY; Gao Z; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Feb; 47(2):108-116. PubMed ID: 30818938
    [No Abstract]   [Full Text] [Related]  

  • 35. Association of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and major adverse cardiac and cerebrovascular events in patients with coronary heart disease undergoing percutaneous coronary intervention: a cohort study.
    Ren X; Wang X
    Curr Med Res Opin; 2023 Sep; 39(9):1175-1181. PubMed ID: 37560911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Outcome of patients with coronary artery disease and left ventricular ejection fraction less than 50% undergoing percutaneous coronary intervention].
    Jiang L; Song Y; Xu JJ; Tang XF; Wang HH; Jiang P; Gao LJ; Song L; Gao Z; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1058-1066. PubMed ID: 29325366
    [No Abstract]   [Full Text] [Related]  

  • 37. Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: insights from the PROTECT ΙΙ study.
    Cohen MG; Ghatak A; Kleiman NS; Naidu SS; Massaro JM; Kirtane AJ; Moses J; Magnus Ohman E; Džavík V; Palacios IF; Heldman AW; Popma JJ; O'Neill WW
    Catheter Cardiovasc Interv; 2014 Jun; 83(7):1057-64. PubMed ID: 24174321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.
    Dixon SR; Henriques JP; Mauri L; Sjauw K; Civitello A; Kar B; Loyalka P; Resnic FS; Teirstein P; Makkar R; Palacios IF; Collins M; Moses J; Benali K; O'Neill WW
    JACC Cardiovasc Interv; 2009 Feb; 2(2):91-6. PubMed ID: 19463408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ejection Fraction Improvement Following Contemporary High-Risk Percutaneous Coronary Intervention: RESTORE EF Study Results.
    Wollmuth J; Patel MP; Dahle T; Bharadwaj A; Waggoner TE; Chambers JW; Ruiz-Rodriguez E; Mahmud E; Thompson C; Morris DL;
    J Soc Cardiovasc Angiogr Interv; 2022; 1(5):100350. PubMed ID: 39131473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.